Jazz Pharmaceuticals (JAZZ) Other Accumulated Expenses (2010 - 2012)

Jazz Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $18.9 million for Q2 2012.

• In Q2 2012, Other Accumulated Expenses changed N/A year-over-year to $18.9 million; the TTM figure through Jun 2012 stood at $18.9 million (changed N/A YoY), while the FY2011 annual figure was $2.4 million, up 135.65% from the prior year.
• Other Accumulated Expenses was $18.9 million for Q2 2012 at Jazz Pharmaceuticals, up from $8.2 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $18.9 million in Q2 2012 to a low of $1.0 million in Q4 2010.
• Historically, Other Accumulated Expenses has averaged $7.6 million across 3 years, with a median of $5.3 million in 2011.
• Biggest YoY gain for Other Accumulated Expenses was 135.65% in 2011; the steepest drop was 135.65% in 2011.
• A 3-year view of Other Accumulated Expenses shows it stood at $1.0 million in 2010, then jumped by 135.65% to $2.4 million in 2011, then surged by 673.8% to $18.9 million in 2012.
• The last three Other Accumulated Expenses figures came in at $18.9 million (Q2 2012), $8.2 million (Q1 2012), and $2.4 million (Q4 2011), per Business Quant data.